Literature DB >> 20857103

Two-stage breast cancer screening in the developing world.

Charalabos Batsis.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 20857103     DOI: 10.1007/s00268-010-0808-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  14 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

2.  Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

3.  Performance of common genetic variants in breast-cancer risk models.

Authors:  Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

Review 4.  Systems medicine: a real approach for future personalized oncology?

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

5.  Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment.

Authors:  Dimitrios H Roukos; Christos Katsios; Theodore Liakakos
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

6.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

7.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

Review 9.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344

View more
  1 in total

Review 1.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.